Duration: 01.05.2015 - 31.12.2019   Contract No 654190


EU-NCL   European Laboratory for Nanomedical Characterization

EU Framework Program Horizon 2020

Aim of the lab:
To bring significantly more nanotherapeutic applications onto the market, i.e., into everyday clinical practice. This should primarily benefit patients, but also the European pharmaceutical industry.
To achieve this as quickly as possible, the EU-NCL is working closely with the only international reference institute in this field, the Nanotechnology Characterization Laboratory (US-NCL) of the US National Cancer Institute. This should lead to a faster international harmonization of analytical methods.
The EU-NCL is also in direct contact with the national drug agencies and the European Medicines Agency (EMA). This allows the analytical services to be directly adapted to the specifications of the regulatory authorities.